Basics Day One Biopharmaceuticals, Inc. IPO Date: May 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $638.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.88% Avg Daily Range (30 D): $0.20 | 2.85% Avg Daily Range (90 D): $0.26 | 2.99% Institutional Daily Volume Avg Daily Volume: .66M Avg Daily Volume (30 D): 1.19M Avg Daily Volume (90 D): 1.05M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 90 Avg Trade Size (Sh.) (90 D): 81 Institutional Trades Total Inst.Trades: 1,419 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $1.04M Avg Inst. Trade (90 D): $1.14M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.88M Avg Closing Trade (30 D): $1.03M Avg Closing Trade (90 D): $1.16M Avg Closing Volume: 131.18K         News Oct 22, 2024 @ 6:33 PM Global Cancer Antibody Drug Conjugates Market Size... Source: Kuick Research Jun 19, 2024 @ 2:29 PM Day One (DAWN) In-Licenses MabCare Cancer Candidat... Source: Zacks Equity Research Jun 18, 2024 @ 12:30 PM Day One Expands Pipeline with Potential First-in-C... Source: Day One Biopharmaceuticals, Inc. May 30, 2024 @ 12:30 PM Day One Announces Sale of Priority Review Voucher ... Source: Day One Biopharmaceuticals, Inc. May 6, 2024 @ 8:30 PM Day One Reports First Quarter 2024 Financial Resul... Source: Day One Biopharmaceuticals, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.71 $-.35 $-.69 Diluted EPS $-.71 $-.35 $-.69 Revenue $ 161.92M $ 30.76M $ 29.21M Gross Profit $ $ $ Net Income / Loss $ -10M $ M $ -6.47M Operating Income / Loss $ -191.57M $ -41.07M $ -65.33M Cost of Revenue $ $ $ Net Cash Flow $ -145.42M $ M $ -297.8M PE Ratio